(PharmaNewsWire.Com, May 17, 2017 ) Asia-Pacific In-Vitro Fertilization (IVF) Market research report published by Market Data Forecast estimates that the market is growing with a CAGR of 18.4% to reach USD 0.63 billion by 2021, from USD 0.27 billion in 2016, which amounts to a cumulative growth of USD 0.36 billion.
In-vitro fertilization (IVF) involves the fertilization of ovum using laboratory settings followed by implantation into uterus. In-vitro fertilization is also known as assisted reproductive technology. The process involves the collection of matured healthy eggs and sperms from the partners, or known or anonymous donors. These eggs get fertilized using laboratory reagents & media and instruments.
Fertilized eggs (embryos) are implanted into uterus for the continuation of development of embryo to child. One cycle of in-vitro fertilization takes around 10-15 days. IVF is most widely accepted method for the fertility treatments in clinical industry and helpful for the couples with infertility problems, single mothers, as well as LGBT communities. The major product categories that assist in-vitro fertilization method include reagents & media (such as embryo culture media, sperm processing media) and instruments (sperm separation system, cryosystems).
The report also presents detailed analysis of multitude of factors affecting Asia-Pacific In-Vitro Fertilization (IVF) Market bearing either positive or negative outcomes. Some of those factors are
Presence of huge number of in-vitro fertilization clinics
Increasing fertility tourisms, and
Rising government initiatives relating to the development of healthcare infrastructure in certain countries of Asia-Pacific (India, China, & Japan)
Rising surrogacy, growing rate of polycystic ovarian syndrome (PCOS)
Increasing number of assisted reproductive technologies (ART) in Asian countries (Australia, New Zealand) are further
For granular level understanding, the Asia-Pacific In-Vitro Fertilization (IVF) Market is segmented based on type each being provided with Market Size Estimations and Y-o-Y ForecastsBased on reagents & media, the market is further sub-segmented as embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. Of these, cryopreservation media accounted for the largest share of Asia-Pacific in-vitro fertilization market by reagents & media in 2015. Based on instruments, the market is segmented as imaging systems, sperm separation systems, ovum aspiration pumps, incubators, micromanipulator systems, cryosystems, and other instruments (gas analyzers, laser systems, accessories). Based on technology, the market is segmented as intra-cytoplasmic sperm injection, pre-implantation genetic diagnosis, frozen embryo transfer/replacement, and other technologies. Based on end users, the market is segmented as fertility & surgical centers, hospitals & research laboratories, and cryobanks.
On the basis of geographical areas, Asia-Pacific in-vitro fertilization market is segmented as Japan, China, India, Australia, and South Korea. With India and China being the major economies which have unexplored customer base covered in the study the report also focuses on other regions like Japan, Australia, South Korea and Rest of Asia-Pacific . China is expected to possess the major chunk of the market whereas Japan is the fastest growing in terms of CAGR.
The key players in in-vitro fertilization market such as, CooperSurgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), EMD Serono, Inc. (U.S.), Genea Limited (Australia), ESCO Micro Pte. Limited (Singapore), IVFtech ApS (Denmark), and the Baker Company, Inc. (U.S.).
Among based on instruments, imaging systems commanded the largest share of Asia-Pacific in-vitro fertilization market by instruments in 2015, whereas, sperm separation systems segment is expected to grow at the highest CAGR during forecast period 2015-2020.Among based on technology, intra-cytoplasmic sperm injection segment accounted for the largest share of Asia-Pacific in-vitro fertilization market by technology in 2015. Of end user, fertility & surgical centers segment commanded the largest share of Asia-Pacific in-vitro fertilization market by end users in 2015.
The Asia-Pacific In-Vitro Fertilization (IVF) Market report offers wide-range of scope:
Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
Know more about key areas of industry growth via detailed Segment-level analysis on basis of type with market size forecasts and y-o-y estimations
Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
Strategic Analyses containing PESTLE and Porters Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Asia-Pacific In-Vitro Fertilization (IVF) Market:
Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
